Rezolute's three largest insider shareholders as of May 14, 2026 are Young-Jin Kim (Director, 8.42Mn shares), Nevan C Elam (Ceo, 613.50K shares), Daron Evans (Cfo, 414.46K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Young-Jin Kim | - | 0 | 8,423,386 | 19 Jun, 2025 |
| Nevan C Elam | Ceo | 613,501 | 0 | 04 Mar, 2026 |
| Daron Evans | Cfo | 414,462 | 0 | 31 Mar, 2026 |
| Brian Kenneth Roberts | Chief Medical Officer | 296,913 | 0 | 04 Mar, 2026 |
| Young-Jin Kim | - | 170,950 | 0 | 20 Nov, 2025 |
| Wladimir Hogenhuis | - | 119,675 | 0 | 17 Dec, 2025 |
| Sunil Ratilal Karnawat | Chief Commercial Officer | 71,542 | 0 | 15 Dec, 2025 |
| Nerissa Kreher | - | 58,576 | 0 | 21 Nov, 2025 |
| Philippe Fauchet | - | 55,500 | 0 | 20 Nov, 2025 |
| Gil M Labrucherie | - | 55,500 | 0 | 20 Nov, 2025 |
| Gil M Labrucherie | - | 0 | 53,572 | 09 May, 2022 |
| Gil M Labrucherie | - | 52,631 | 0 | 06 May, 2022 |
| Wladimir Hogenhuis | - | 41,767 | 0 | 24 Sep, 2024 |
| Daron Evans | Cfo | 0 | 40,000 | 14 Jun, 2024 |
| Daron Evans | Cfo | 0 | 23,000 | 27 Mar, 2025 |
| Brian Kenneth Roberts | Sr Vp, Clinic Development | 22,552 | 0 | 19 May, 2022 |
| Erik Harris | - | 21,000 | 0 | 20 Nov, 2025 |
| Daron Evans | Cfo | 0 | 20,000 | 15 Mar, 2024 |
| Brian Kenneth Roberts | Chief Medical Officer | 0 | 14,376 | 14 Jun, 2024 |
| Daron Evans | Cfo | 0 | 14,000 | 15 Dec, 2025 |
| Daron Evans | Cfo | 0 | 13,000 | 28 May, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Mar, 2026 | Daron Evans | Common Shares | A | 10,000 | $2.85 | 414,462 | D | P |
| 02 Mar, 2026 | Nevan C Elam | Common Shares | D | 27,618 | $2.99 | 613,501 | D | F |
| 02 Mar, 2026 | Daron Evans | Common Shares | D | 11,438 | $2.99 | 404,462 | D | F |
| 02 Mar, 2026 | Brian Kenneth Roberts | Common Shares | D | 11,439 | $2.99 | 296,913 | D | F |
| 16 Dec, 2025 | Wladimir Hogenhuis | Common Shares | A | 5,650 | $1.69 | 119,675 | D | P |
| 16 Dec, 2025 | Brian Kenneth Roberts | Common Shares | A | 28,000 | $1.70 | 308,352 | D | P |
| 15 Dec, 2025 | Nevan C Elam | Common Shares | A | 32,000 | $1.59 | 641,119 | D | P |
| 15 Dec, 2025 | Daron Evans | Common Shares | A | 40,000 | $1.77 | 415,900 | D | P |
| 15 Dec, 2025 | Sunil Ratilal Karnawat | Common Shares | A | 12,000 | $1.62 | 71,442 | D | P |
| 15 Dec, 2025 | Sunil Ratilal Karnawat | Common Shares | A | 100 | $1.60 | 71,542 | D | P |
| 15 Dec, 2025 | Daron Evans | Common Shares | A | 2,500 | $1.79 | 7,000 | I | P |
| 15 Dec, 2025 | Daron Evans | Common Shares | A | 2,500 | $1.79 | 7,000 | I | P |
| 19 Nov, 2025 | Nerissa Kreher | Common Shares | A | 21,000 | $0.00 | 58,576 | D | A |
| 19 Nov, 2025 | Daron Evans | Common Shares | A | 107,000 | $0.00 | 375,900 | D | A |
| 19 Nov, 2025 | Nevan C Elam | Common Shares | A | 317,000 | $0.00 | 609,119 | D | A |
| 19 Nov, 2025 | Brian Kenneth Roberts | Common Shares | A | 123,000 | $0.00 | 280,352 | D | A |
| 19 Nov, 2025 | Sunil Ratilal Karnawat | Common Shares | A | 32,000 | $0.00 | 59,442 | D | A |
| 19 Nov, 2025 | Wladimir Hogenhuis | Common Shares | A | 21,000 | $0.00 | 114,025 | D | A |
| 19 Nov, 2025 | Nerissa Kreher | Director Stock Option (Right to Buy) | A | 12,000 | $0.00 | 12,000 | D | A |
| 19 Nov, 2025 | Nevan C Elam | Employee Stock Option (Right to Buy) | A | 186,000 | $0.00 | 186,000 | D | A |